Univariable Cox Analyses for DMFS in Training Cohort*
Parameter | HR† | c-index | P |
---|---|---|---|
Clinical | |||
Age, in y | 1.020 (0.990–1.051) | 0.540 | 0.197 |
Sex | |||
Female | Reference | ||
Male | 1.861 (0.738–4.694) | 0.532 | 0.188 |
Tobacco | |||
No | Reference | ||
Yes | 2.112 (0.760–5.874) | 0.533 | 0.152 |
Alcohol | |||
No | Reference | ||
Yes | 1.111 (0.634–1.945) | 0.517 | 0.714 |
PS | |||
0–1 | Reference | ||
2 | 0.963 (0.133–6.988) | 0.502 | 0.970 |
T classification | |||
cT1–cT2 | Reference | ||
cT3–cT4 | 6.795 (1.981–23.334) | 0.660 | 0.002 |
N classification | |||
cN0 | Reference | ||
cN1 | 1.432 (0.530–3.874) | 0.638 | 0.479 |
cN2 | 3.034 (1.518–6.088) | 0.638 | 0.002 |
cN3 | 3.851 (1.072–13.827) | 0.638 | 0.039 |
AJCC staging | |||
I | Reference | ||
II | 1.389 (0.196–9.865) | 0.595 | 0.742 |
III | 3.116 (0.647–15.006) | 0.595 | 0.156 |
IV | 4.513 (1.089–18.708) | 0.595 | 0.038 |
Tumor site | |||
Oral cavity | Reference | ||
Hypopharynx | 1.946 (0.914–4.140) | 0.578 | 0.084 |
Larynx | 0.875 (0.374–2.049) | 0.578 | 0.759 |
Oropharynx | 1.094 (0.507–2.361) | 0.578 | 0.818 |
Metabolic data | |||
Tumor metabolic data | |||
SUVmax | 1.040 (1.010–1.072) | 0.617 | 0.009 |
MTV at 15% of SUVmax | 1.026 (1.016–1.036) | 0.709 | < 0.0001 |
MTV at SUV of 4.0 | 1.033 (1.020–1.046) | 0.720 | 0.0000005 |
TLG at 21% of SUVmax | 1.003 (1.002–1.005) | 0.720 | <0.0001 |
TLG at SUV of 4.0 | 1.003 (1.002–1.004) | 0.714 | 0.0000008 |
Node metabolic data | |||
MTV at 21% of SUVmax | 1.011 (1.000–1.021) | 0.694 | 0.04 |
MTV at SUV of 3.0 | 1.016 (1.007–1.026) | 0.693 | 0.0002 |
TLG at 21% of SUVmax | 1.002 (1.001–1.003) | 0.698 | 0.004 |
TLG at SUV of 3.0 | 1.002 (1.001–1.026) | 0.694 | 0.0006 |
Distance parameters | |||
Maximal tumor–node distance | 1.177 (1.092–1.269) | 0.679 | 0.00002 |
dst_MTVweightedSumDistTN | 1.002 (1.001–1.004) | 0.696 | 0.00003 |
dst_MTVweightedMaxDistTN | 1.003 (1.001–1.006) | 0.68 | 0.01 |